Next-Generation Sequencing
The latest news on next-generation sequencing.
MSInsight Nabs €1.6M in Seed Funding to Develop Microsatellite Instability Cancer Dx Software
The French cancer diagnostics startup plans to obtain regulatory approval for its MSIcare software as an in vitro diagnostic medical device for MSI cancers.
GenomOncology, Pillar Biosciences Partner to Develop NGS-Driven Clinical Decision Support Solution
In the deal, GenomOncology will integrate Pillar's RUO NGS panels into its clinical decision support platform to enable personalized cancer treatment insights.
The research hospital is working to further validate and refine its approach, aiming to arm clinicians with a more comprehensive tool to personalize care.
Caris Life Sciences Expands Access to Urologic Cancer Tests Through Deal With Lumea
The firms agreed to make Caris' whole-exome and whole-transcriptome sequencing tests available through Lumea's BxLink digital pathology software.
Caris Life Sciences CDx Assay Nabs FDA Approval
The whole-exome sequencing and whole-transcriptome sequencing-based test is approved for molecular profiling of solid tumors.
Jul 11, 2024